Natalija Novak's research works | University of Bonn, Bonn (Uni Bonn) and other places
ARA-cell 100 mg/ml Konzentrat
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy. - Abstract - Europe PMC
ARA-cell 1000 mg/4000 mg Infusionslösung
Anhang
Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä
Regulatory T cells and myeloid-derived suppressor cells in metastatic renal cell carcinoma: Modulation by sorafenib and sunitini
Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
STADApharm
Tabellenanhang - Familie Alex, Weingarten
US10517852B2 - Solid forms of bendamustine hydrochloride - Google Patents
Inhaled Medicines: Past, Present, and Future | Pharmacological Reviews
ARA-cell® | STADA
Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules
Cytarabin - Anwendung, Wirkung, Nebenwirkungen | Gelbe Liste
ARA-cell® 1000 mg Infusionslösung
Janus-Type Dendrimers Based on Highly Branched Fluorinated Chains with Tunable Self-Assembly and 19F Nuclear Magnetic Resonance Properties | Macromolecules
Identification of solubility-limited absorption of oral anticancer drugs using PBPK modeling based on rat PK and its relevance to human - ScienceDirect
Liste von Abkürzungen/List of Abbreviations - DPI - Home
Kriterien zur Bestimmung der zweckmäßigen Vergleichstherapie und Recherche und Synopse der Evidenz zur Bestimmung der zweckmä
Informationen zur zweckmäßigen Vergleichstherapie
STADAPHARM
US10517852B2 - Solid forms of bendamustine hydrochloride - Google Patents
